Research programme: GTP-binding protein inhibitors - Ipsen
Alternative Names: BIM-46174; BIM-46187Latest Information Update: 28 Oct 2018
At a glance
- Originator Ipsen
- Developer Institut Henri Beaufour-Ipsen; Ipsen; Oncodesign Biotechnology
- Class Imidazoles; Small molecules
- Mechanism of Action G protein-coupled receptor modulators; GTP-binding protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer; Cancer pain
Most Recent Events
- 28 Oct 2018 No recent reports of development identified for preclinical development in Cancer in France (PO)
- 28 Oct 2018 No recent reports of development identified for preclinical development in Cancer-pain(Chemotherapy-induced) in France (Parenteral, Injection)
- 13 Dec 2010 Preclinical development is ongoing in France